Project Grant HT94252310929
Award Date 9/15/23
Completion Date 9/14/26
Dollars Obligated $749K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
- The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,997 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a pharmacology and efficacy study of a novel, blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The Military...
- The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $544,892.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop a novel peptide-drug conjugate for precision-targeted DNA damage in neuroendocrine tumors. The award period is from August 1, 2025 to July 31, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
- The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
- The Defense Health Agency awarded a $3,150,000 Project Grant to the University of Texas Health Science Center at San Antonio (UTHSCSA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The project will be performed in San Antonio, TX and runs from...
- The University of Texas Health Science Center at Houston (UTHealth) received a $777,586 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2027, will fund the "Stress Inoculation Training (SIT): An Evidence-Driven, Military-Aligned Psychological Performance and Health Sustainment Prototype" research project. The project...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...